News

A novel HIV vaccine candidate induces neutralising antibodies after a single dose in primates, potentially accelerating HIV prevention strategies.

A personalised multipeptide T cell activator induced durable immune responses and showed an acceptable safety profile in patients with chronic lymphocytic leukaemia in a phase one trial.

The secondary SOUL trial analysis shows oral semaglutide reduces heart failure events in patients with diabetes and pre-existing heart failure.

Residential wood burning contributes substantially to winter PM2.5 pollution in the USA, linked to thousands of premature deaths.

HPV testing using menstrual blood showed comparable accuracy to clinician-collected samples in detecting high-grade cervical lesions in a large population study.

Presented at EAHAD 2026 and awarded third best poster, this multicentre study demonstrates that product-specific calibration improves the accuracy of factor VIII activity measurement across assay platforms.

Drug-resistant infections such as MRSA are widespread among children in Oceania, with major gaps in access and approved treatments.

Novel non-invasive liver disease assessments (NILDAs) are effective liver biopsy alternatives for fibrosis, a 2026 systematic review has found.